Fuzuloparib Capsules are a PARP inhibitor indicated for the treatment of specific cancers, primarily malignant tumors such as ovarian cancer and fallopian tube cancer. Their price is influenced by factors including specification, region, and medical insurance policies, generally ranging from US$$362 to U$$578 per box. For specific pricing, please refer to information provided by local hospitals or formal pharmacies.
Factors Affecting Price
Specification Differences
Total cost varies by specification (e.g., number of capsules per box or single-capsule dosage); the corresponding product should be selected in accordance with a prescription.
Medical Insurance Policies
This drug has been included in the medical insurance lists of some provinces and cities, with reimbursement ratios varying by region. It is recommended to consult the local medical insurance authority or the treating hospital.
Purchase Channels
Prices may differ across hospitals, designated pharmacies, or compliant online platforms. Purchase only through formal channels to avoid medicines from unconfirmed sources.
Precautions for Use
Administer as Prescribed: Fuzuloparib is a prescription medication. Strictly follow the dosage and treatment course prescribed by your doctor; do not adjust the dose or discontinue treatment without medical advice.
Adverse Reactions
Common side effects include anemia, nausea, fatigue, etc. If symptoms worsen or allergic reactions (e.g., skin rash, dyspnea) occur, seek immediate medical attention.
Contraindications and Cautions
Patients with severe hepatic or renal impairment, those who are pregnant or breastfeeding, should inform their doctor in advance for a risk assessment before use.
Other Recommendations
Regular Follow-ups
During treatment, undergo blood tests and imaging evaluations as directed by your doctor to monitor therapeutic efficacy and safety.
Storage:
Store in a cool, dry place below 25°C, protected from light and sealed. Keep out of reach of children.
For further details on administration or pricing, please contact your attending physician or consult a qualified medical institution to ensure safe and effective treatment.
